These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 108675)

  • 21. Ribonucleotide reductase activity and deoxyribonucleoside triphosphate metabolism during the cell cycle of S49 wild-type and mutant mouse T-lymphoma cells.
    Albert DA; Gudas LJ
    J Biol Chem; 1985 Jan; 260(1):679-84. PubMed ID: 2981227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanine for DNA synthesis. A compulsory route through ribonucleotide reductase.
    Duan DS; Sadee W
    Biochem J; 1988 Nov; 255(3):1045-8. PubMed ID: 3063254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical genetic analysis of the role of methylthioadenosine phosphorylase in a murine lymphoid cell line.
    Kubota M; Kamatani N; Carson DA
    J Biol Chem; 1983 Jun; 258(12):7288-91. PubMed ID: 6408072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deoxyguanosine toxicity on lymphoid cells as a cause for immunosuppression in purine nucleoside phosphorylase deficiency.
    Chan TS
    Cell; 1978 Jul; 14(3):523-30. PubMed ID: 99242
    [No Abstract]   [Full Text] [Related]  

  • 25. Functional and mechanistic studies on the toxicity of deoxyguanosine for the in vitro proliferation and differentiation of human peripheral blood B lymphocytes.
    Scharenberg JG; Spaapen LJ; Rijkers GT; Duran M; Staal GE; Zegers BJ
    Eur J Immunol; 1986 Apr; 16(4):381-7. PubMed ID: 3084280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
    Mitchell BS; Kelley WN
    Ann Intern Med; 1980 Jun; 92(6):826-31. PubMed ID: 6247948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different pathways for deoxyguanosine toxicity in T-lymphocytes of various developmental stages.
    Scharenberg JG; Rijkers GT; Spaapen LJ; Toebes EA; Rijksen G; Duran M; Staal GE; Zegers BJ
    Int J Immunopharmacol; 1988; 10(6):675-86. PubMed ID: 2974022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme defects and immune dysfunction.
    Rosen FS
    Nature; 1978 Dec; 276(5688):559-60. PubMed ID: 102999
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immune insufficiency in enzyme defects of purine metabolism].
    Müller G
    Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposed explanation for S-adenosylhomocysteine hydrolase deficiency in purine nucleoside phosphorylase and hypoxanthine-guanine phosphoribosyltransferase-deficient patients.
    Hershfield MS
    J Clin Invest; 1981 Mar; 67(3):696-701. PubMed ID: 6782120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulatory mutants for the synthesis of a 2d purine nucleoside phosphorylase in Escherichia coli K-12. I. Synthesis inducers and the substrate specificity of purine nucleoside phosphorylase in pndR mutants].
    Kocharian ShM; Kocharian AM; Melkumian MA; Bezirdzhian KhO; Akopian ZhI
    Genetika; 1984 Sep; 20(9):1463-71. PubMed ID: 6437906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary immunodeficiencies and purine metabolism].
    Romo Cortina A; Lorente Toledano F; Salazar Villalobos V
    Rev Clin Esp; 1985 Oct; 177(6):247-53. PubMed ID: 3001848
    [No Abstract]   [Full Text] [Related]  

  • 33. Deoxyadenosine toxicity and cell cycle arrest in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA; Nodzenski E
    Exp Cell Res; 1988 Dec; 179(2):417-28. PubMed ID: 3056732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purine nucleoside phosphorylase deficiency. Measurement of variant protein in four families with enzyme-deficient members by an enzyme-linked immunosorbent assay.
    Osborne WR; Scott CR
    Am J Hum Genet; 1980 Nov; 32(6):927-33. PubMed ID: 6778206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.
    Cohen A; Doyle D; Martin DW; Ammann AJ
    N Engl J Med; 1976 Dec; 295(26):1449-54. PubMed ID: 825775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune deficiency due to adenosine deaminase and purine nucleoside phosphorylase deficiency: a simple diagnostic test.
    Maddocks JL; Al-Safi SA; Wilson G
    J Clin Pathol; 1984 Nov; 37(11):1305-7. PubMed ID: 6438186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rat model of purine nucleoside phosphorylase deficiency.
    Osborne WR; Barton RW
    Immunology; 1986 Sep; 59(1):63-7. PubMed ID: 3019875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purine nucleoside phosphorylase deficiency.
    Markert ML
    Immunodefic Rev; 1991; 3(1):45-81. PubMed ID: 1931007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.
    Carson DA; Carrera CJ
    Semin Hematol; 1990 Jul; 27(3):260-9. PubMed ID: 2115692
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary purines in a patient with a severely defective T cell immunity and a purine nucleoside phosphorylase deficiency.
    Wadman SK; de Bree PK; van Gennip AH; Stoop JW; Zegers BJ; Staal GE; Siegenbeek LH
    Adv Exp Med Biol; 1977; 76A():471-6. PubMed ID: 404853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.